מעקב אחר ליפידים של נובו באמצעות תיוג איזוטופ יציב LC-TIMS-TOF MS/MS

Executive Industry Relevance

Stable isotope labeling combined with LC-TIMS-TOF MS/MS enables high-throughput, quantitative tracing of de novo lipid synthesis and dynamics in complex biological samples. This approach addresses the critical need for standardization and reproducibility in lipidomics, supporting confident target validation and mechanistic de-risking in early discovery. The protocol's ability to resolve lipid structures at the fatty acid chain level enhances predictive confidence for translational and preclinical research pipelines.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables precise interrogation of lipid metabolic pathways using stable isotope-labeled tracers.
• Supports functional target validation by quantifying de novo lipid synthesis and turnover.
• Reduces mechanistic ambiguity in lipid biology through high-resolution structural assignment.
• Facilitates portfolio triage by providing robust, quantitative lipidomic data.

Screening & Assay Development

• Prepares validated lipidomic systems for downstream screening workflows.
• Delivers standardized, reproducible, and quantitative outputs for assay development.
• Enables high-throughput screening readiness with single-sample, single-scan analysis.
• Supports reliable compound evaluation by minimizing endogenous interference.

Translational & Preclinical Research

• Aligns lipidomic measurements with disease-relevant biological processes, such as ovary development in model organisms.
• Provides continuity from discovery through preclinical validation by tracking lipid dynamics over time.
• Enables risk-adjusted advancement decisions based on quantitative biomarker data.
• Enhances predictive de-risking for translational biomarker strategies.

Pipeline & Workflow Integration

This method integrates from early discovery through lead identification and preclinical research, supporting hypothesis testing and quantitative pathway analysis in lipid metabolism.

• Discovery Biology: Facilitates hypothesis-driven interrogation of lipid synthesis and mobilization using SIL tracers.
• Screening: Provides assay-ready, reproducible, and quantitative lipidomic outputs for compound evaluation.
• Analytics: Delivers high-resolution measurements of retention time, mobility, and fragmentation for confident lipid assignment.
• Translational Research: Supports biomarker alignment and continuity across discovery and preclinical stages.
• Enterprise Reuse: Establishes a standardized, scalable workflow for lipidomics applicable across diverse biological systems.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and target validation by resolving lipid structure-function relationships.
• Operational Value: Drives standardization, reproducibility, and scalability in lipidomic analyses.
• Strategic Value: Enables informed go/no-go decisions and reduces late-stage biological risk through robust data.
• Portfolio Impact: Supports risk-adjusted prioritization and advancement of lipid-targeted programs.

Implementation Considerations

• Requires expertise in mass spectrometry, stable isotope labeling, and lipidomics data analysis.
• Demands access to LC-TIMS-TOF MS/MS instrumentation and advanced analytical software.
• Necessitates rigorous calibration and cross-team standardization for reproducible results.
• Adaptable to various biological models but may require optimization for specific sample types.
• Potential limitations include the need to minimize endogenous interference and ensure accurate isotope enrichment calculations.

Biopharma FAQs